8VG-19788-38570
2 vaccinations
1 coded response
3 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 770 / TX
- Registered
- 2021-02-26
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-27
Dose 1 — Pfizer-BioNTech
-
2021-02-24
Dose 2 — Pfizer-BioNTech
-
2021-02-26
Registered in v-safe
- 2021-02-26
- 2021-02-27
-
2021-08-27
Survey response — 6 months, dose 2MedDRA: COVID-19, Nasopharyngitis, Rhinorrhoea, Throat irritation — Feeling: GoodFree text: Positive for Covid. Felt like a mild cold. Scratchy throat and runny nose.MedDRA releases: 2021-09,2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-27 | Pfizer-BioNTech | |
| 2 | 2021-02-24 | Pfizer-BioNTech |
Free text
Release 9 — 6 months, dose 2
Symptoms: Positive for Covid. Felt like a mild cold. Scratchy throat and runny nose.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | COVID-19 | ✓ | · | ✓ |
| SD | Nasopharyngitis | ✓ | · | ✓ |
| SD | Rhinorrhoea | ✓ | · | ✓ |
| SD | Throat irritation | ✓ | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release